ReviewCancers2022
Systemic Therapy for Oligoprogression in Patients with Metastatic NSCLC Harboring Activating EGFR Mutations.
Antonio Rossi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ReviewCancers2022
Antonio Rossi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.